IVMA - Key Persons
Job Titles:
- Director
- Executive Secretary
- Member of the Managing Committee
Job Titles:
- Chairman of the Managing Committee
- Managing Director
- Vice President / Chairman & Managing Director, Bharat Biotech International Ltd, Hyderabad
Under Dr. Ella's exemplary leadership, driven with the belief that innovative modern technology in vaccine development is of paramount importance to improve public healthcare system, Bharat Biotech has emerged a global leader in innovative vaccine, since its incorporation in 1996. As a member of various central committees, Dr. Ella has been instrumental in shaping a robust outline of India's science education and policies. Several awards have been conferred on Dr. Ella including the ET Now Special Recognition for Healthcare Industry Award
Job Titles:
- Managing Director
- Member of the Managing Committee
- Member / Managing Director, Panacea Biotec, New Delhi
Dr. Rajesh Jain's visionary leadership and passion for innovative solutions has enabled Panacea Biotec to explore new horizons and develop an diversified product pipeline for global public health impact through affordable new and innovative medical therapies. Dr. Jain also has 31 granted patents with another 33 under various stages of grant - in the field of vaccines, drug discovery and drug delivery. Dr. Jain is associated as the Vice-President of the Indian Pharmaceutical Association, Chairman of the Confederation of Indian Industry's National Committee on Biotechnology, among other initiatives that enable holistic development of Indian Industry and Healthcare Infrastructure. The Global Alliance for Vaccines and Immunizations (GAVI) and Bill & Melinda Gates Foundation have recognised Rajesh Jain's efforts towards producing affordable vaccines for mass population across the globe.
Job Titles:
- Executive Director
- Member of the Managing Committee
- Executive Director of Serum Institute of India Ltd
- Member / Serum Institute of India
Dr. Suresh Jadhav is Executive Director of Serum Institute of India Ltd. His significant contribution to the holistic development and growth has played a key role in pushing SII to new heights and becoming one of the largest vaccine manufacturers worldwide. Apart from his association with elite international organizations including Developing Countries Vaccine Manufacturers' Network (DCVMN) GAVI, Task Force of Sabin Vaccine Institute, WHO IVR-IVAC and Decades of Vaccines (DoV) etc, he also has more than 60 100 technical papers published in International / National journals and two patents credited to his name.
Job Titles:
- Chief Executive Officer
- Member of the Managing Committee
- President / Chief Executive Officer, Serum Institute of India, Pune
As the Chief Executive Officer (CEO) and Executive Director of Serum Institute of India (SII), Adar has led the institute to become India's largest vaccine manufacturer and one of the world's leading biotech company. Since joining SII in 2001, Adar has been working relentlessly to push forward the company's growth and operations in the healthcare industry, which was started by his father, Dr. Cyrus Poonawalla. Notably, he has been instrumental in expanding SII's capabilities and building mammoth assembly lines in meeting vaccine requirements of India and other low-and-middle income countries. Staying true to its commitment of providing affordable vaccines, since he taken over, the company's supply chain has increased to 170 nations from 35 countries, manufacturing 1.5 billion doses of WHO pre-qualified, life-saving vaccines.
Job Titles:
- Member of the Managing Committee
- Treasurer / Serum Institute of India
Job Titles:
- Member of the Managing Committee
- Chief Executive - Biologicals
Mr. Suri known for his consultative management style, has been former Member-Policy & Planning Committee (PPC) of GAVI, as also a Member of GAVI Steering Committee for Supply & Procurement Strategy. He has served as Member Executive Committee & Vice-President, DCVMN. Mr Suri has played a lead role in negotiations & interactions with Ministry of Health, Government of India, UN agencies and other Global organizations like WHO, UNICEF, Bill & Melinda Gates Foundation, Clinton Health Access Initiative & several others. Currently he is representing Panacea Biotec on the Board of EBPMN (Emerging Bio Pharmaceutical Manufacturers Network) and Chair, Covid 19 Control & Prevention Committee (CCPC), Panacea Biotec.
Job Titles:
- Managing Director
- Member of the Managing Committee
- Managing Director of Biological E Limited
- Member / Managing Director, Biological E. Ltd, Hyderabad
Mahima Datla is currently the Managing Director of Biological E Limited wherein she over sees the strategic operations within the organisation. Under Ms Mahima Datla's impeccable leadership, Biological E Limited has witnessed massive growth and achieved various milestones including the successful WHO pre-qualification and launch of the Pentavalent and JE vaccines. Ms Datla is also associated with various international organizations including FICCI, CII (Confederation of Indian Industry) National Biotech committees in India, DCVMN (Developing Countries Vaccine Manufacturers Network), Global Health Innovative Technology fund etc.